# Drug Use Investigation Of Effexor (SECONDARY DATA COLLECTION STUDY; SAFETY AND EFFICACY OF EFFEXOR.UNDER JAPANESE MEDICAL PRACTICE)

> **NCT02958527** · — · COMPLETED · sponsor: **Pfizer's Upjohn has merged with Mylan to form Viatris Inc.** · enrollment: 1408 (actual)

## Conditions studied

- Depression/Depressed State

## Interventions

- **DRUG:** venlafaxine

## Key facts

- **NCT ID:** NCT02958527
- **Lead sponsor:** Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-10-03
- **Primary completion:** 2020-05-11
- **Final completion:** 2020-05-11
- **Target enrollment:** 1408 (ACTUAL)
- **Last updated:** 2023-05-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02958527

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02958527, "Drug Use Investigation Of Effexor (SECONDARY DATA COLLECTION STUDY; SAFETY AND EFFICACY OF EFFEXOR.UNDER JAPANESE MEDICAL PRACTICE)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02958527. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*